The Alsinova patient platform is a digital tool already used in therapeutic areas very similar to SLE (Systemic Lupus Erythematosus) and rheumatoid arthritis, offering strong security guarantees and low adaptation costs. The availability of this tool to collect...
Celltrion | YU-MATTER | IBD & RIC | e-cohort
The YU-MATTER study is a patient-centered e-cohort designed to assess overall patient satisfaction with the injection of Yuflyma (a biosimilar of adalimumab) three months after the first injection, compared to their experience with their previous adalimumab treatment....
CHU Lille | MentCovRMD | COVID-19 | e-cohorte
MentCovRMD is a cross-sectional observational RIPH3 study aiming to assess the socio-psychological consequences in patients with chronic rheumatism, systemic autoimmune or autoinflammatory diseases who have experienced COVID-19. The COVID-19 pandemic and the...
INSULET | OPTIMAL-A | Diabetes | IC DM
The Omnipod 5 automated insulin delivery system was approved by French authorities in January 2024 and has been marketed in France since June 2024. As the first tubeless HCL system available in France, Omnipod 5 combines a discreet, tubeless pump with a CGM sensor and...
European Hospital | AutoEvaLUP | Lupus | e-cohort and SNDS
The AutoEvaLUP study focuses on adult patients suffering from systemic lupus erythematosus (fatigue, pain, anxiety, depression). The primary objective of the study is to evaluate the predictive performance of flare occurrence through monthly longitudinal assessment of...
Internal Study | Retro-ARV | HIV | SNDS
Rétro-ARV is a study aiming to investigate the treatment history and care pathways of HIV patients in France. The goal is to identify therapeutic changes over the past ten years and document the types and durations of treatments received or taken by HIV-positive...
Strasbourg University Hospitals | COMBATT | Inflammatory Diseases | e-cohort
COMBATT is a national observatory of targeted therapies administered in combination for various refractory immune-mediated inflammatory diseases. Its main objective is to evaluate the safety/tolerance of targeted treatments (in mono- or combination therapy)...
CETONES-SFDT1 | ABBOTT | Diabetes | Ambispective Survey | Retrospective Study
CÉTONES is a project by ABBOTT Laboratories focused on identifying barriers to ketone self-monitoring in patients with type 1 diabetes (T1D), and describing subgroups of patients likely to use the new Freestyle Libre dual glucose and ketone sensor. This study...
ARDRM | Metabo-Nutri-COVID | COVID
The Metabo-Nutri-COVID study focuses on metabolic markers and prognosis of COVID-19 infections in the acute hospitalization setting. Study period: Q4 2020 Role of Alsinova: Co-design the data collection eCRF and perform statistical analyses with our partner...
AFPric & Saint-Etienne University Hospital | MethoFolic | IRD | Survey
This AFPric survey targets individuals living with rheumatoid arthritis, treated with methotrexate and folic acid supplementation, aged 18 or older. It aims to assess satisfaction with treatment administration and whether alternative methods might be helpful or more...